Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATN-161 and Carboplatin in Recurrent Malignant Glioma
NCT00352313Phase 2Completed
- Sponsor
- National Institutes of Health
- Start
- May 2006
- Primary completion
- Jan 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of ATN161 in malignant glioma, sponsored by National Institutes of Health. Started May 2006; status: completed.
02
Drugs
ATN161
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00352313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00352313.